Skip to main content
PACS
NYSE Industrial Applications And Services

Officer and Director Mark Hancock files intent to sell $6.44 million in PACS Group stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$45
Mkt Cap
$7.122B
52W Low
$7.5
52W High
$45.89
52W Position info
500% above low
Off High info
1.9% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PACS has more than doubled off its 52-week low of $7.5.

Summary

Officer and Director Mark Hancock intends to sell $6.44 million in PACS Group stock, continuing a trend of significant insider sales while the stock is near its 52-week high.


Key Events · Ownership and Investor Activity · PACS

  • Intent to Sell Significant Shares

    Officer and Director Mark Hancock filed a Form 144 to sell 142,163 shares of common stock, valued at approximately $6.44 million.

  • Ongoing Insider Distribution

    This proposed sale follows previous sales by Hancock totaling nearly $20 million over the past three months, indicating a sustained pattern of insider selling.

  • Stock Trading Near 52-Week High

    The intent to sell comes as PACS Group's stock is trading near its 52-week high of $45.89, potentially signaling profit-taking by the insider.


Analysis · PACS · Industrial Applications And Services

Mark Hancock, an Officer and Director, has filed a Form 144 indicating his intent to sell $6.44 million worth of PACS Group common stock. This proposed sale adds to a pattern of significant insider selling by Hancock, who has already sold nearly $20 million in shares over the past three months. The filing occurs while the stock is trading near its 52-week high, suggesting the insider is taking profits. This ongoing distribution by a key executive could be viewed negatively by investors.

At the time of this filing, PACS was trading at $45.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $7.50 to $45.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PACS - Latest Insights

PACS
Aug 04, 2026, 4:45 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $45.15
Real-time Price: $48.95 info
Change: +$3.80 (+8%) info
Market Cap: $7.67B info
PACS
Aug 04, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $44.62
Real-time Price: $48.95 info
Change: +$4.33 (+10%) info
Market Cap: $7.67B info
PACS
Aug 04, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $44.62
Real-time Price: $48.95 info
Change: +$4.33 (+10%) info
Market Cap: $7.67B info
PACS
Jun 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $39.94
Real-time Price: $48.95 info
Change: +$9.01 (+23%) info
Market Cap: $7.67B info
PACS
Jun 26, 2026, 2:22 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $41.18
Real-time Price: $48.95 info
Change: +$7.77 (+19%) info
Market Cap: $7.67B info